These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29705998)

  • 1. Photoacoustic imaging system visualizes restoration of peripheral oxygenation in psoriatic lesions.
    Ishida Y; Otsuka A; Honda T; Asao Y; Sekiguchi H; Yoshikawa A; Yagi T; Kabashima K
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):e449-e451. PubMed ID: 29705998
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination of antitumour necrosis factor-α and anti-interleukin-12/23 antibodies in refractory psoriasis and psoriatic arthritis: a long-term case-series observational study.
    Gniadecki R; Bang B; Sand C
    Br J Dermatol; 2016 May; 174(5):1145-6. PubMed ID: 26522308
    [No Abstract]   [Full Text] [Related]  

  • 3. Alemtuzumab and chronic plaque psoriasis.
    Aslam A; Marsland AM; Rog D; Griffiths CE
    Br J Dermatol; 2013 Jul; 169(1):184-6. PubMed ID: 23834118
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple lentigines in areas of resolving psoriatic plaques after ustekinumab therapy.
    Gutiérrez-González E; Batalla A; de la Mano D
    Dermatol Online J; 2014 Apr; 20(4):22338. PubMed ID: 24746301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ustekinumab associated with flares of psoriatic arthritis.
    Stamell EF; Kutner A; Viola K; Cohen SR
    JAMA Dermatol; 2013 Dec; 149(12):1410-3. PubMed ID: 24132520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ustekinumab for the treatment of HIV psoriasis.
    Paparizos V; Rallis E; Kirsten L; Kyriakis K
    J Dermatolog Treat; 2012 Dec; 23(6):398-9. PubMed ID: 21787206
    [No Abstract]   [Full Text] [Related]  

  • 7. A scientific debate: key clinical questions in the management of psoriasis.
    Stingl G
    J Eur Acad Dermatol Venereol; 2012 Aug; 26 Suppl 5():1. PubMed ID: 22758910
    [No Abstract]   [Full Text] [Related]  

  • 8. High pulse energy fibre laser as an excitation source for photoacoustic tomography.
    Allen TJ; Berendt M; Lin D; Alam SU; Huynh NT; Zhang E; Richardson DJ; Beard PC
    Opt Express; 2020 Nov; 28(23):34255-34265. PubMed ID: 33182899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of serious gastrointestinal events among tildrakizumab-treated patients with psoriasis: Letter to the Editor.
    Gooderham M; Elewski BE; Pariser DM; Sofen H; Mendelsohn AM; Rozzo SJ; Li Q
    J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):e350-e352. PubMed ID: 31033068
    [No Abstract]   [Full Text] [Related]  

  • 10. Good efficacy and tolerability of ustekinumab in a patient with severe psoriasis under haemodialysis.
    Larquey M; Poreaux C; Cuny JF; Barbaud A; Schmutz JL
    Eur J Dermatol; 2014; 24(5):618-9. PubMed ID: 25445092
    [No Abstract]   [Full Text] [Related]  

  • 11. Real-life efficacy and safety of secukinumab: results from a tertiary hospital in Greece.
    Tsentemeidou A; Sotiriou E; Vakirlis E; Sideris N; Papadimitriou I; Lazaridou E; Ioannides D
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):e50-e51. PubMed ID: 29959803
    [No Abstract]   [Full Text] [Related]  

  • 12. Simultaneous photoacoustic imaging of intravascular and tissue oxygenation.
    Chen M; Knox HJ; Tang Y; Liu W; Nie L; Chan J; Yao J
    Opt Lett; 2019 Aug; 44(15):3773-3776. PubMed ID: 31368965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ixekizumab for treatment of adults with moderate-to-severe plaque psoriasis and psoriatic arthritis.
    Vu TT; Gooderham M; Papp K
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1423-1433. PubMed ID: 27690669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilia during psoriasis treatment with TNF antagonists.
    Malisiewicz B; Murer C; Pachlopnik Schmid J; French LE; Schmid-Grendelmeier P; Navarini AA
    Dermatology; 2011; 223(4):311-5. PubMed ID: 22301393
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of tumour necrosis factor-α inhibitor- and rituximab-induced plantar pustular psoriasis that completely resolved with tocilizumab.
    Jayasekera P; Parslew R; Al-Sharqi A
    Br J Dermatol; 2014 Dec; 171(6):1546-9. PubMed ID: 24890762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resident Rounds. Part III A. Serendipitous improvement in moderate to severe acne in psoriasis patients treated with ustekinumab: a two-case series.
    Jensen JD; Huynh T; Cafardi J; Sami N
    J Drugs Dermatol; 2013 Jun; 12(6):710-1. PubMed ID: 23839194
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab.
    Chew AL; Bennett A; Smith CH; Barker J; Kirkham B
    Br J Dermatol; 2004 Aug; 151(2):492-6. PubMed ID: 15327561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching biological agents for psoriasis in secondary care: a single-centre, retrospective, open-label study.
    Woo WA; Waite A; Rustin MH; McBride SR
    Br J Dermatol; 2014 Apr; 170(4):989-90. PubMed ID: 24298875
    [No Abstract]   [Full Text] [Related]  

  • 19. The successful treatment with ixekizumab in a multi-failure psoriasis patient.
    Azevedo A; Torres T
    Dermatol Online J; 2018 Sep; 24(9):. PubMed ID: 30677837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical treatment habits in psoriasis patients receiving adalimumab.
    Kolios AG; Rusca F; Reisenbauer K; Cozzio A; French LE; Navarini AA
    Dermatology; 2012; 224(3):228-30. PubMed ID: 22414626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.